ANU-Genentech collaboration exposes a new mechanism involved in sepsis »

A gene involved in the development of sepsis has been discovered by a long-standing collaboration between teams at the Australian National University and Genentech, a member of the Roche Group.

Funding continues for rare disease research in Canberra »

Genomics testing in the ACT is being further embedded into the Canberra health system with a new agreement signed between Canberra Health Services (CHS) and the Australian National University (ANU) to continue their joint diagnostic venture, Canberra Clinical Genomics.